| Filed On | Filing |
|---|---|
| 22 Jun 2026 |
Form 3: Mathew Marlyn Teresa, VP, Principal Acctg. Officer
Holds 129,182 shares of Class A Ordinary Shares |
| 05 Mar 2026 |
Form 3: Nirula Ajay, Director
No securities owned |
| 24 Feb 2026 |
Form 3: Eisner Mark, Director
No securities owned |
| 27 Jan 2026 | Form 3: Thiara Parvinder, Director |
| 02 Jan 2026 |
Form 3: Athanor Capital, 10% owner and 1 other
Holds 11,581,402 shares of Class A Ordinary Shares, par value $0.0001 per share |
| 17 Jul 2025 |
Form 3: Hyllengren Eric J, Chief Financial Officer
No securities owned |
| 29 May 2025 |
Form 3: Becker Daniel J., Director
No securities owned |
| 28 May 2025 |
Form 3: Ai Biotechnology Llc, 10% owner and 3 others
Holds 4,552,725 shares of Class A Ordinary Shares |
| 08 Jan 2024 |
Form 3: Lisicki Robert, See Remarks
No securities owned |
| 07 Dec 2023 |
Form 3: Nistala Kiran, Executive Vice President
No securities owned |
| 17 Nov 2023 |
Form 3: Ploos van Amstel Arnout, Director
Holds 20,000 shares of Class A ordinary shares |
| 02 Oct 2023 |
Form 3: Thiara Parvinder, Director
Holds 6,801,633 shares of Class A Ordinary Shares |
| 13 Apr 2023 |
Form 3: Ewon Comfortech Co., Ltd., 10% owner
Holds 2,000,000 shares of Class A Ordinary Shares, par value $0.0001 |
| 04 Apr 2023 |
Form 3: Hana Immunotherapeutics Llc, 10% owner and 1 other
Holds 5,404,274 shares of Class A Ordinary Shares, par value $0.0001 |
| 31 Mar 2023 |
Form 3: Barclays Plc, 10% owner
Holds 2,340,240 shares of Class A Ordinary Shares, par value $0.0001 per share |
| 30 Mar 2023 |
Form 3: Pfizer Inc, 10% owner
Holds 2,970,022 shares of Class A Ordinary Shares, $0.0001 par value |
| 30 Mar 2023 |
Form 3: Athanor Capital, Lp, 10% owner
Holds 6,801,633 shares of ZURA BIO LTD. |
| 21 Mar 2023 | Form 3: Kulkarni Sandeep Chidambar, Director |
| 21 Mar 2023 | Form 3: Whale Gary, EVP and CTO |
| 21 Mar 2023 | Form 3: Schoch Steven J, Director |
Loading...
